RA
The study was       designed as a randomized trial and a single DMARD or two or three DMARD       combinations were administered to 180 consecutive, age- and sex-matched patients        with active RA, each of whom was followed up for a period of 2 years under       treatment.
The study was       designed as a randomized trial and a single DMARD or two or three DMARD       combinations were administered to 180 consecutive, age- and sex-matched  @OBJECT$          @PREDICAT$  active  @SUBJECT$ , each of whom was followed up for a period of 2 years under       treatment.